Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial

Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:30:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:20:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:01:30.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:40.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, indicating an access restriction. This suggests a server-side issue or blocked access to the study record page.
    Difference
    17%
    Check dated 2026-09-20T20:26:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Locations list now includes Tel Litwinsky, Israel, 52621 as a new site and removes Qiryat Krinitzi, Israel, 52621 from the study locations.
    Difference
    0.1%
    Check dated 2026-09-13T21:40:35.000Z thumbnail image

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.